CLASS SOCESP 2013 Mortality is dose-dependent red blood cells transfused units after coronary artery bypass grafting CLASS Brazilian Congress of Cardiology 2012 30-day mortality Associated with Transfusion of Red Blood Cells after coronary artery bypass grafting CLASS Brazilian Congress of Cardiology 2011 Management Protocol Conservation Blood in Thoracic Surgery Serious and Complex Class: Patient Blood…

Different from what happens with any medicine before being released to be used in human beings, blood has never gone through safety and effectiveness tests. According to the strict FDA (Food and Drug Administration) rules, if BLOOD was a MEDICINE, a medication, it would have HARDLY got the approval of this organ to be used…

After almost two centuries of blood transfusions, modern medicine faces the challenge of restricting more and more the medical transfusion practice. PHYSICIANS and physicians treat the patient’s ANEMIA THE PHYSICIAN of ALL PHYSICIANS treats the PATIENT who has got anemia. The physician attention shall be the anemia’s patient, not the patient’s anemia. Non-Transfusion Modern Medicine,…

There are multiple therapeutic resources to reduce or avoid allogenic blood transfusion (other person’s blood). These options involve clinic strategies with medicine and/or specific equipment to treat the patient with anemia and/or blood coagulation disorder (for instance, low platelet). On the other hand, there are also surgical strategies with evidences to reduce blood loss by…

Bloodless is a widely known term and commonly used to describe surgeries and other procedures performed without the use of homologous/allogeneic blood (someone else’s blood). For this purpose was designed the www.bloodless.br Web site for showing to both health professionals and the general population, the main therapeutic options and/or strategies for reducing or even avoiding…

2017 © Copyright - Bloodless

Interaktiv